1. Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma
   Weiyi Zhang, 2023, Medicine CrossRef
2. TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
   Liu Yang et al, 2023, Clinical Medicine Insights: Oncology CrossRef
3. Design, synthesis, cytotoxic and enzyme inhibitory activities of 1,3,4-oxadiazole and 1,3,4-thiadiazine hybrids against non-small cell lung cancer
   Abdelsalam Mohamed Abdelsalam Ouf et al, 2022, Results in Chemistry CrossRef
4. A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
   Sólrún Melkorka Maggadóttir et al, 2022, Frontiers in Oncology CrossRef
5. Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates
   Jennifer L. Fisher et al, 2024, FEBS Open Bio CrossRef
6. Mechanisms Involved in the Therapeutic Effect of Cannabinoid Compounds on Gliomas: A Review with Experimental Approach
   Hugo Fernandes Oliveira Pires et al, 2024, Current Protein & Peptide Science CrossRef
7. Association of TERT (rs2736098 and rs2736100) genetic variants with elevated risk of hepatocellular carcinoma: a retrospective case–control study
   Walaa R. Seif Eldin et al, 2023, Scientific Reports CrossRef
8. Role of STK11 in ALK‑positive non‑small cell lung cancer (Review)
   Wen Zhou et al, 2022, Oncology Letters CrossRef
9. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients
   Bin Liu et al, 2024, Scientific Reports CrossRef
10. New Genetic Bomb Trigger: Design, Synthesis, Molecular Dynamics Simulation, and Biological Evaluation of Novel BIBR1532-Related Analogs Targeting Telomerase against Non-Small Cell Lung Cancer
    Haytham O. Tawfik et al, 2022, Pharmaceuticals CrossRef